Company / Total Assets
Cocrystal Pharma, Inc. Total Assets History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$79.4M
FY2021
5-year range
$7.2M / $79.4M
FY2017-FY2021
Trend
+46.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has increased for 3 consecutive years, from $7M in FY2012 to $79M in FY2021.
Based on SEC 10-K filings.
$79M in FY2021.
Improved from $29M to $79M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Cocrystal Pharma, Inc.'s total assets has grown for 3 consecutive years.
- In FY2021, total assets increased 46.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $79.4M | +46.4% |
| FY2020 | $54.2M | +90.1% |
| FY2019 | $28.5M | +294.1% |
| FY2012 | $7.2M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026